OnCore Login

Return to Trial Database

HCRN-LUN01-25

Phase Ib/IIa Study of an Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination with Carboplatin-Paclitaxel in Patients with Chemo-therapy Naïve Advanced Non Small Cell Lung Cancer

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

A Multi-Centered Phase I/II Study of Cetuximab in Combination with Paclitaxel and Carboplatin in Untreated Patients with Stage IV Non-Small Cell Lung Cancer
  • K Kelly, N Hanna, A Rosenberg, P Bunn Jr., MN Needle

Trial Locations

All sites in which the trial HCRN-LUN01-25 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278